Randa Jaafar
Pain Medicine · New York, NYNPI 1619126208
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 60.8% of it on its own, with 50 other manufacturers making up the rest. Reporting peaked in 2019 at $54,320 and has fallen 98.5% since, to $803 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 539 payments — averaging $162.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$53K
- Boston Scientific$21K
- Nevro Corp.$4K
- Kowa Pharmaceuticals America, Inc.$2K
- Merz North America, Inc.$1K
- Amgen$883
- plus $5K from 45 others
What the payments were for
- Consulting fees$5,3006%
- Speaking & faculty fees$51,64559%
- Travel & lodging$10,07012%
- Food & beverage$20,41023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUCEMYRA$28,509
- RELISTOR$22,018
- SPECTRA WAVEWRITER$16,758
- Senza Spinal Cord Stimulation System$2,082
- Seglentis$1,700
- WaveWriter Alpha Prime 16$1,528
- GENERAL PAIN MANAGEMENT$807
- Biomet SpinalPak Non-invasive Spine Fusion Stimulator System$362
- Azur CX Detachable$325
- COVEREDGE$268
- Omnia$264
- VECTRIS$240
- Senza$235
- Provena Midline$235
- XEOMIN$163
- HydroPearl$163
- Navicross$163
- SUPERION$151
- BOTOX$150
- KRYSTEXXA$150
How this compares
$87,424 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 11 | $117 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in New York
- Amitabh GulatiNew York$614K
- David SpinnerNew York$391K
- Eric LeeNew York$117K
- Christopher GhariboNew York$91K
- Boris LeybelNew York$58K
- Chirag ShahNew York$48K
- Annie Layno-MosesNew York$29K
- Raj MurthyNew York$24K
- David CassagnolNew York$22K
- Scott MaddaloNew York$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.